Breaking Biotech (@BreakingBioMatt) header
Breaking Biotech (@BreakingBioMatt) profile picture

Biotech investor/trader - Host of Breaking Biotech https://teapaw.org/t.co/P6wtEkED8z [email protected]

San Diego, CA
Joined September 2017
Photo by Breaking Biotech (@BreakingBioMatt)Photo by Breaking Biotech (@BreakingBioMatt)Photo by Breaking Biotech (@BreakingBioMatt)Photo by Breaking Biotech (@BreakingBioMatt)Photo by Breaking Biotech (@BreakingBioMatt)Photo by Breaking Biotech (@BreakingBioMatt)Photo by Breaking Biotech (@BreakingBioMatt)Photo by Breaking Biotech (@BreakingBioMatt)
Breaking Biotech retweeted
*EISAI, BIOGEN GET ACCELERATED APPROVAL FOR ALZHEIMER’S DRUG
7
18
3
89
87,690
Breaking Biotech retweeted
Check out Breaking Biotech’s recent interview with our CEO, John Bencich and @MatthewLepoire to learn more about the ongoing development of cytisinicline for #smokingcessation. Click here to view the full interview: youtube.com/watch?v=NEAzxbP-… #quitsmoking
2
4
$RHHBY — TIGIT — $RCUS $ITOS $MRK $BMY $MREO Disappointing first P3 results, in ES-SCLC, for Roche/Genen anti-TIGIT, TIRA. The CITY Skyline could still be filled, but as of yet, no Skyscrapers for TIRA:
2
3
1
4
Breaking Biotech retweeted
*FDA DENIES CITIZEN PETITION ON CASSAVA DRUG $SAVA
5
7
4
41
Breaking Biotech retweeted
CymaBay’s CEO Sujal Shah was recently a guest on the Breaking Biotech podcast with @MatthewLepoire where he shared details on Primary Biliary Cholangitis (PBC) and seladelpar. Watch the full conversation here: youtube.com/watch?v=G4uEDGnN… #PBC #Podcast #RareDisease #LiverDisease
2
6
Breaking Biotech retweeted
$LGVN short interest is $8M 381.61K shares shorted 14.20 % SI% of Float 12.43 % S3 SI% Float 113.57 % fee Shares shorted down -31K shs, worth $621K, -7.44 %, over the last week. Shorts down -$6M in 2021 mark-to-market losses; including +$244K on today's -3.36 % move.
5
5
2
16
Breaking Biotech retweeted
#NEWS: Today w/ @Pfizer, we announced that updated safety & efficacy data from our jointly developed investigational novel PROTAC® protein degrader will be presented in a poster-discussion session at @SABCSSanAntonio. Learn more: https://teapaw.org/t.co/Naw5AqiAlv #SABCS21
4
3
14
Breaking Biotech retweeted
LIFESCI $ALXO (OUTPERFORM,$87.00 PT): SITC update: Mixed outcome as gastric update shines and head and neck data disappoint
1
5
Breaking Biotech retweeted
Check out the latest #podcast episode of #BreakingBiotech where our President & CEO, @JohnGHouston, sat down with @MatthewLepoire to discuss the exciting progress of our #PROTAC technology. ⬇️
3
6
Breaking Biotech retweeted
4D Molecular Therapeutics Announces Late-Breaking Presentation of 4D-125 Clinical Data at the Upcoming ASRS Annual Meeting - 4D Molecular Therapeutics $FDMT moment of truth! ir.4dmoleculartherapeutics.c…
1
1
3
Breaking Biotech retweeted
$APLS halt
1
1
Breaking Biotech retweeted
13
5
1
23
Breaking Biotech retweeted
U.S. FDA CALLS FOR FEDERAL INVESTIGATION INTO ITS CONTROVERSIAL ALZHEIMER’S DRUG APPROVAL - STAT NEWS $BIIB
11
21
12
118
Breaking Biotech retweeted
$ALXO Oncology Announces New Data from ASPEN-01, the Phase 1b--- ORR of 72% Observed in Patients with >2L HER2 Positive Gastric or Gastroesophageal Junction Cancer -- Estimated OS at 12 months of 76% Conference Call on July 6th at 8:30 a.m. ET globenewswire.com/news-relea…
4
4
2
21
Breaking Biotech retweeted
$FDMT - preclinical NHP wet AMD data on May 12th - abstract notes "no evidence of chronic intraocular inflammation"
3
2
6